Lonza Biologics, Inc.

Form 483 issued November 3, 2020 · Portsmouth, New Hampshire

Inspection
Jan 3 – Nov 3, 2020
Investigator
Wayne Seifert
Observations
3
Pages
3
FEI number
3001451441

In short: On November 3, 2020, FDA issued a Form 483 with 3 observations to Lonza Biologics, Inc. in Portsmouth, New Hampshire (FEI 3001451441) after an inspection that ran Jan 3 – Nov 3, 2020. The investigator was Wayne Seifert. Most observations concern production and facilities & equipment.

At a glance

2 of 3 observations on this 483 concern production.

Production2
Facilities & equipment1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    A (b)(4) utility used in manufacture has…

  2. 02

    Manufacturing equipment has not been adequately installed and facilities…

  3. 03

    Standard Operating procedures or work instructions are not…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Lonza Biologics, Inc.?

FDA listed 3 observations on this Form 483, mostly about production and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected Lonza Biologics, Inc.?

Wayne Seifert is named on this Form 483, for the inspection of Jan 3 – Nov 3, 2020. Each investigator has a profile showing what they cite most.

When was Lonza Biologics, Inc. inspected by FDA?

The inspection ran Jan 3 – Nov 3, 2020, and the Form 483 is dated November 3, 2020.

How do I get the full Form 483 for Lonza Biologics, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free